Literature DB >> 16353694

Structural heart diseases in Nigerian children.

M O Asani1, M U Sani, K M Karaye, S I Adeleke, U Baba.   

Abstract

BACKGROUND: Cardiovascular diseases both in adults and children constitute a major public health problem and structural heart diseases are an important group of disorders in children worldwide. The pattern of this group of disorders however, varies between regions and countries and even within countries. Recognizing the structural cardiac conditions that prevail in a particular area is important in health planning and for improving health care services. The present survey sets out to describe the pattern of structural heart diseases among children in Aminu Kano Teaching Hospital, Kano from our echocardiography data.
METHODS: The echocardiographic reports of all children seen in Aminu Kano Teaching Hospital, Kano between August 2002 and September 2004 (24 months) were reviewed. Information obtained from the records includes age, gender, clinical diagnosis and echocardiographic findings. Data was analyzed using SPSS version 10.0 software.
RESULTS: A total of 108 children, aged between two weeks and eighteen years, were referred for echocardiographic examination in the 2-year study period. Of these, 88 had an abnormal echocardiogram. There were 55 boys and 31 girls, giving a male and female ratio of 1.8:1. Congenital heart diseases accounted for 55 (62.5%) of the studied subjects while acquired heart diseases were responsible for 33 (37.5%). Isolated ventricular septal defect (VSD) was the commonest congenital heart disease. Rheumatic valvular heart diseases were the commonest acquired structural heart disease.
CONCLUSION: With the establishment of tertiary healthcare institutions in Nigeria, availability of echocardiographic facilities as well as increasing number of paediatric cardiologists, more of these cases are likely to be seen in the future. There is an urgent need for the government to establish a well equipped cardiothoracic surgical centre to cater for these patients either free or at highly subsidized rates.

Entities:  

Mesh:

Year:  2005        PMID: 16353694     DOI: 10.4314/njm.v14i4.37190

Source DB:  PubMed          Journal:  Niger J Med        ISSN: 1115-2613


  7 in total

Review 1.  A systematic review of trends and patterns of congenital heart disease in children in Nigeria from 1964-2015.

Authors:  Mohammed Abdulkadir; Zainab Abdulkadir
Journal:  Afr Health Sci       Date:  2016-06       Impact factor: 0.927

Review 2.  Genomics and Epigenomics of Congenital Heart Defects: Expert Review and Lessons Learned in Africa.

Authors:  Nicholas Ekow Thomford; Kevin Dzobo; Nana Akyaa Yao; Emile Chimusa; Jonathan Evans; Emmanuel Okai; Paul Kruszka; Maximilian Muenke; Gordon Awandare; Ambroise Wonkam; Collet Dandara
Journal:  OMICS       Date:  2018-05

3.  A new look at acquired heart diseases in a contemporary sub-Saharan African pediatric population: the case of Yaoundé, Cameroon.

Authors:  Clovis Nkoke; Alain Menanga; Jerome Boombhi; David Chelo; Samuel Kingue
Journal:  Cardiovasc Diagn Ther       Date:  2015-12

4.  Systemic Comorbidity in Children with Cataracts in Nigeria: Advocacy for Rubella Immunization.

Authors:  Roseline Duke; Sidney Oparah; Adedayo Adio; Okon Eyo; Friday Odey
Journal:  J Ophthalmol       Date:  2015-08-17       Impact factor: 1.909

5.  Nigerian Children with Acquired Heart Disease: The Experience in Lagos.

Authors:  Barakat Adeola Animasahun; Akpoembele Deborah Madise-Wobo; Olusola Yejide Kusimo
Journal:  J Tehran Heart Cent       Date:  2017-10

6.  Childhood acquired heart diseases in Jos, north central Nigeria.

Authors:  Fidelia Bode-Thomas; Olukemi O Ige; Christopher Yilgwan
Journal:  Niger Med J       Date:  2013-01

7.  The burden of rheumatic heart disease among children in Lagos: how are we fairing?

Authors:  Barakat Adeola Animasahun; Akpoembele Deborah Madise Wobo; Adejumoke Yemisi Itiola; Motunrayo Oluwabukola Adekunle; Olusola Yejide Kusimo; Fidelia Bode Thomas
Journal:  Pan Afr Med J       Date:  2018-03-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.